IL116828A - Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment or prophylaxis of cerebral degenerative disorders - Google Patents
Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment or prophylaxis of cerebral degenerative disordersInfo
- Publication number
- IL116828A IL116828A IL11682896A IL11682896A IL116828A IL 116828 A IL116828 A IL 116828A IL 11682896 A IL11682896 A IL 11682896A IL 11682896 A IL11682896 A IL 11682896A IL 116828 A IL116828 A IL 116828A
- Authority
- IL
- Israel
- Prior art keywords
- prophylaxis
- preparation
- treatment
- pharmaceutical compositions
- degenerative disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK6895 | 1995-01-20 | ||
DK77695 | 1995-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL116828A0 IL116828A0 (en) | 1996-05-14 |
IL116828A true IL116828A (en) | 1999-11-30 |
Family
ID=26063233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11682896A IL116828A (en) | 1995-01-20 | 1996-01-19 | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment or prophylaxis of cerebral degenerative disorders |
Country Status (13)
Country | Link |
---|---|
US (2) | US5696149A (xx) |
EP (1) | EP0809495A1 (xx) |
JP (1) | JPH10512269A (xx) |
KR (1) | KR19980701549A (xx) |
CN (1) | CN1168101A (xx) |
AU (1) | AU4328896A (xx) |
BR (1) | BR9606766A (xx) |
CA (1) | CA2208856A1 (xx) |
CZ (1) | CZ212097A3 (xx) |
HU (1) | HUP9702246A3 (xx) |
IL (1) | IL116828A (xx) |
NO (1) | NO973342L (xx) |
WO (1) | WO1996022091A1 (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9610875A (pt) | 1995-10-06 | 1999-07-13 | Ligand Pharm Inc | Modulares rxr seletivos - dimeros e processos para seu uso |
US5756539A (en) * | 1996-07-11 | 1998-05-26 | Novo Nordis A/S | 3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders |
US5958967A (en) * | 1996-10-28 | 1999-09-28 | Novo Nordisk A/S | Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
AU5550498A (en) * | 1997-01-29 | 1998-08-18 | Novo Nordisk A/S | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting one or more psychiatric disorders |
WO2006032085A1 (en) | 2004-09-21 | 2006-03-30 | Novogen Research Pty Ltd | Substituted chroman derivatives, medicaments and use in therapy |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
AU2008229617A1 (en) * | 2007-03-16 | 2008-09-25 | Novogen Research Pty Ltd | Method for inducing autophagy |
US20100130598A1 (en) * | 2008-10-22 | 2010-05-27 | Novogen Research Pty Ltd. | Methods for inducing programmed cell death |
JP6013349B2 (ja) | 2010-11-01 | 2016-10-25 | メイ ファーマ, インク.Mei Pharma, Inc. | 癌の処置のためのイソフラボノイド化合物および方法 |
US9701655B2 (en) | 2014-02-07 | 2017-07-11 | Novogen Limited | Functionalised benzopyran compounds and use thereof |
MX2017010002A (es) | 2015-02-02 | 2018-02-09 | Mei Pharma Inc | Terapias de combinacion. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3822287A (en) * | 1969-04-17 | 1974-07-02 | Rexall Drug Chemical | Process for preparation of substituted 3,4-(diphenyl)chromans |
US4447622A (en) * | 1981-09-22 | 1984-05-08 | Council Of Scientific And Industrial Research Rafi Marg | Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
US5451603A (en) * | 1993-03-11 | 1995-09-19 | Zymogenetics, Inc. | 3,4-diarylchromans for treatment of dermatitis |
DE4311870C2 (de) * | 1993-04-10 | 1998-07-30 | Altramed Holdings Ltd | Verwendung eines Anti-Östrigens zur Therapie und Prophylaxe von Demenz-Erkrankungen |
DE4320896A1 (de) * | 1993-06-24 | 1995-01-05 | Denecke Rainer Dr Med Vet | Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen |
US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
-
1996
- 1996-01-10 JP JP8521976A patent/JPH10512269A/ja active Pending
- 1996-01-10 CN CN96191516A patent/CN1168101A/zh active Pending
- 1996-01-10 AU AU43288/96A patent/AU4328896A/en not_active Abandoned
- 1996-01-10 KR KR1019970704940A patent/KR19980701549A/ko not_active Application Discontinuation
- 1996-01-10 CA CA002208856A patent/CA2208856A1/en not_active Abandoned
- 1996-01-10 WO PCT/DK1996/000010 patent/WO1996022091A1/en not_active Application Discontinuation
- 1996-01-10 CZ CZ972120A patent/CZ212097A3/cs unknown
- 1996-01-10 EP EP96900091A patent/EP0809495A1/en not_active Withdrawn
- 1996-01-10 HU HU9702246A patent/HUP9702246A3/hu unknown
- 1996-01-10 BR BR9606766A patent/BR9606766A/pt not_active Application Discontinuation
- 1996-01-11 US US08/585,012 patent/US5696149A/en not_active Expired - Fee Related
- 1996-01-19 IL IL11682896A patent/IL116828A/xx active IP Right Grant
-
1997
- 1997-01-10 US US08/783,420 patent/US5827873A/en not_active Expired - Fee Related
- 1997-07-18 NO NO973342A patent/NO973342L/no unknown
Also Published As
Publication number | Publication date |
---|---|
HUP9702246A2 (hu) | 1998-12-28 |
JPH10512269A (ja) | 1998-11-24 |
CA2208856A1 (en) | 1996-07-25 |
CZ212097A3 (en) | 1997-11-12 |
NO973342D0 (no) | 1997-07-18 |
US5827873A (en) | 1998-10-27 |
MX9705390A (es) | 1997-10-31 |
US5696149A (en) | 1997-12-09 |
WO1996022091A1 (en) | 1996-07-25 |
AU4328896A (en) | 1996-08-07 |
KR19980701549A (ko) | 1998-05-15 |
CN1168101A (zh) | 1997-12-17 |
HUP9702246A3 (en) | 1999-12-28 |
BR9606766A (pt) | 1997-12-30 |
IL116828A0 (en) | 1996-05-14 |
EP0809495A1 (en) | 1997-12-03 |
NO973342L (no) | 1997-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
HUP9904525A3 (en) | Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan | |
HUP9702244A3 (en) | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders | |
AU4060599A (en) | Pharmaceutical composition for treating or preventing sleep disorders | |
IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
HUP9901807A3 (en) | Heterocycle substituted n-acyl benzenesulfonamide derivatives, process for their preparation and their use as prodrug for the preparation of pharmaceutical compositions treating inflammation or inflammation-associated disorders | |
HUP9701193A3 (en) | Use of n-(4-aryl-thiazol-2-yl)-sulfonamide derivatives for the preparation of pharmaceutical compositions treating neurological disorders, new derivatives, process for their preparation and pharmaceutical compositions containing them | |
IL112895A (en) | Pharmaceutical compositions for the treatment of obsessive-compulsive disorders comprising 5-HT2 antagonists | |
HUP0200287A3 (en) | Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders | |
IL124882A0 (en) | Use of 3, 4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms | |
IL116828A (en) | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment or prophylaxis of cerebral degenerative disorders | |
IL116745A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
IL116826A (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity | |
IL116747A (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment of gynaecomastia | |
IL116827A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
AU686084B3 (en) | Pharmaceutical compositions for the treatment of depressive disorders | |
AU3555793A (en) | Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina | |
ZA96439B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders | |
ZA98682B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders | |
ZA96446B (en) | Use of 3,4-diphenyl chromans for the manufacture of pharmaceutical composition for the treatment or prophylaxis of obesity | |
AU5768298A (en) | Use of benzoylalkyl-1,2,3,6-tetrahydropyridins | |
ZA96440B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis | |
ZA96248B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia | |
IL106917A0 (en) | Compositions for the treatment of skin disorders | |
ZA97170B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted |